An Insight into the Dendritic Cells at the Maternal–Fetal Interface
- 14 December 2004
- journal article
- review article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 52 (6) , 350-355
- https://doi.org/10.1111/j.1600-0897.2004.00232.x
Abstract
The conditions that permit the genetically distinct fetus to survive and develop within the mother are among the most fascinating immunologic puzzles. The presence of dendritic cells in the maternal decidua pointed to a biologic role of antigen-presenting cells in maternal-fetal interaction. The method of study included recent findings on the lineage, maturity, phenotype and function of dendritic cells at the maternal-fetal interface. The increment of uterine dendritic cells occurs simultaneously with the decisive phase of gestation, when implantation takes place. Decidual dendritic cells of the first trimester pregnancy, with a phenotype characteristic of the mature myeloid lineage, express MHC class II, co-stimulatory and adhesion molecules, control Th1/Th2 balance and activate the proliferative response of autologous NK cells. Dendritic cells are specifically equipped to control immunity, to trigger immune response and also to maintain tolerance, avoiding the rejection of the conceptus by the maternal immune system.Keywords
This publication has 45 references indexed in Scilit:
- Characterisation of antigen presenting cells in the human first trimester deciduaAmerican Journal of Reproductive Immunology, 2002
- Potential of tolerogenic dendritic cells for transplantationSeminars in Immunology, 2001
- Human Decidua Contains Potent Immunostimulatory CD83+ Dendritic CellsThe American Journal of Pathology, 2000
- The Role of Chemokine Receptors in Primary, Effector, and Memory Immune ResponsesAnnual Review of Immunology, 2000
- Immunobiology of Dendritic CellsAnnual Review of Immunology, 2000
- The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic CellsThe Journal of Experimental Medicine, 2000
- Reciprocal Control of T Helper Cell and Dendritic Cell DifferentiationScience, 1999
- Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer CellsThe Journal of Experimental Medicine, 1997
- Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.The Journal of Experimental Medicine, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994